Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the HBP Assay to Predict Development of Severe Sepsis in Patients With Suspected Infection Following ED Admission

NCT03113721 is registered in ClinicalTrials.gov with Axis Shield Diagnostics Ltd as lead sponsor.

NCT NCT03113721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03113721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the HBP Assay to Predict Development of Severe Sepsis in Patients With Suspected Infection Following ED Admission
Lead sponsor
Axis Shield Diagnostics Ltd
Phase
Observational
Overall status
Unknown status
Start date
March 27, 2017
Completion date
March 1, 2019
Enrollment
571 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, sepsis with acute organ dysfunction, septic shock